International growth case study: Test and Verification Solutions

Posted by 

SETsquared Bristol

“Our company has grown tremendously under support from SETsquared Bristol.” –  Mike Bartley, T&VS Founder

 

SETsquared Bristol alumni member Mike Bartley is the founder of Test and Verification Solutions (T&VS). Mike gained his PhD in Mathematical Logic at the University of Bristol and has been involved in software testing and hardware verification for over 25 years.

T&VS provides specialist test and verification services and products for the semiconductor and embedded systems industries.

T&VS specialises in ensuring products are reliable, safe and secure. This includes checking medical and healthcare products to ensure they are both safe and secure.

Growing at an impressive pace, the company has offices around the globe. There are five offices in India (including Bangalore, Hyderabad, Noida and two in Chennai), as well as one office in the USA, one in Singapore, two in Europe and another in Japan.

 

Test and Verification Solutions Key Facts:

  • Start date: 2008
  • Market sector: Electronics
  • Location: Bristol, UK
  • Number of employees: 350
  • Company turnover: $8.5 million
  • T&VS website

 

Discover more of the companies SETsquared incubate here and sign up to the monthly SETsquared newsletter to keep up with news, events, opportunities and more.

Recent News, Blogs and Stories

Speakers Laura Gemmell and Andrew Smith at Startup Stories event

Startup Stories: From Idea to Exit

Bristol’s startup community came together recently for the fourth instalment of our SETsquared Bristol Startup Stories series, featuring two fireside chats exploring the founder journey - from the initial startup...
We're hiring

Two new job opportunities at SETsquared Bristol

We are recruiting for two job vacancies, a SETsquared Bristol Manager and an Entrepreneur in Residence. SETsquared Bristol is one of the region's pioneering tech incubators. Since its inception in...
GenomeKey blood sample in lab

Life Sciences spotlight: GenomeKey

Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at...

SUCCESS IS THE GOAL

Fast track your technology business